Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid

NCT00172029 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00172029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00172029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2003
Completion date
Not reported
Enrollment
116 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer with metastatic bone disease